Clinical Trial Update: Use of Topotecan in Patients With Refractory Acute Leukemia [Phase 2]

View source ↗

Summary

Trial update on a Phase 2 study of topotecan in patients with refractory leukemia and non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Non-Hodgkin's Lymphoma, Leukemia | Phase 2 | Status: COMPLETED